While a cure remains elusive, strides in treatment options are increasingly controlling symptoms and giving patients a positive long-term prognosis.
Advances in research are showing promise for new treatments for this chronic and disabling disease.
Billing codes used to seek reimbursement for Hizentra, including supplies, pump and nursing, for a primary immunodeficiency disease
6% hydroxyethyl starch products have been touted as a less-expensive alternative to 5% human albumin for blood volume expansion, but recent published evidence shows that it comes at a price for selected populations.
Despite the widespread belief that asthma is not serious, it’s a potentially lethal illness that can be managed by understanding the facts about how to prevent and treat asthma attacks.
With the rising rates of autoimmune disease, the quest is on to research and develop new medicines to treat patients who often present with multiple disorders.
While the incidence of meningitis is relatively low in the U.S., this dangerous disease can be lethal. Fortunately, preventive vaccines are available.
A look at one Southern California accelerator and two innovative medical breakthroughs poised to improve accuracy in continuous glucose monitoring and pinpoint risk factors following DCIS diagnosis.
When choosing a site of care for immune globulin therapy, each patient’s unique situation needs to be considered.
Researchers have identified a potential new cause for unexplained miscarriages in mice and have identified two possible treatments to prevent these miscarriages.
From dietary supplements and acupuncture to yoga and meditation, many on-the-fringe interventions are becoming more accepted by patients and practitioners.
Pairing genetic testing with treatment therapies helps physicians deliver better care to patients by identifying which therapies will be the most effective at specific doses.